Bone Biologics Corporation
BBLG
$1.40
$0.064.48%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/8/2026
-
Benzinga
5/31/2026
-
The Cerbat Gem
5/19/2026
-
The Fly
4/1/2026
-
Ticker Report
1/8/2026
-
TipRanks Financial Blog
1/8/2026
-
The Fly
1/8/2026
-
GuruFocus
1/8/2026
-
Globe Newswire
12/23/2025
-
The Fly
12/23/2025
-
Globe Newswire
11/16/2025
-
Ticker Report
9/23/2025
-
Ticker Report
9/12/2025
-
Ticker Report
9/4/2025
-
RTT News - Momentum Stocks
9/4/2025
-
GuruFocus
9/4/2025
-
Business Wire
9/3/2025
-
GuruFocus
9/3/2025
-
GuruFocus
9/3/2025
-
Business Wire
6/30/2025
-
GuruFocus
6/30/2025
-
GuruFocus
6/30/2025
-
Business Wire
6/29/2025
-
MarketBeat
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 2, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 552 4452
Address
2 Burlington Woods Drive
Burlington, MA 01803
Burlington, MA 01803
Country
Year Founded
Business Description
Sector
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM...
more